At AGC Pharma Chemicals, our pharmaceutical plant are purpose-built for the development and production of small molecule Active Pharmaceutical Ingredients (APIs) and intermediates. Strategically located in Barcelona and Japan, our facilities operate under strict cGMP compliance and are equipped with advanced technologies to support your project from early development to commercial manufacturing — safely, reliably, and at scale.
What Is a Pharmaceutical Plant for Small Molecule API Manufacturing?
A pharmaceutical plant for Small Molecule APIs is a specialized manufacturing site where Small Molecule APIs are produced under controlled conditions. At AGC Pharma Chemicals, our plants are designed to meet the highest regulatory and quality expectations, including:
- Full cGMP certification
- Regular audits by FDA, EMA, PMDA, and other agencies
- Integrated quality and safety systems
- Capability to handle high-potency APIs (HPAPIs)
- Flexibility to manage multi-stage synthesis and complex chemistries
Inside AGC Pharma Chemicals’ Pharmaceutical Plant
Our two main pharmaceutical manufacturing sites are strategically located in:
Spain (Barcelona area)
Our European center of excellence for cGMP API production, HPAPI handling, and micronization
Japan (Chiba)
A vertically integrated pharmaceutical plant focused on process optimization, scale-up, and global regulatory compliance
Technologies Available in Our Pharmaceutical Plants
At AGC Pharma Chemicals, our pharmaceutical plants are equipped with advanced technologies to carry out complex small molecule synthesis under full cGMP compliance. Our capabilities include:
- Low-temperature reactions (cryogenic chemistry) for safe and precise control of sensitive intermediates
- Hydrogenation under scalable and controlled conditions
- Fluorination technologies to support specialized compound synthesis
- High containment systems for the safe development and manufacturing of HPAPIs (Highly Potent APIs)
- Micronization under cGMP conditions to optimize particle size and bioavailability
- High-pressure reactions and specialized handling of hazardous reagents
- Solvent recovery and in-plant environmental safety systems
Our plants are engineered to safely handle hazardous materials and complex synthesis routes, always within the framework of environmental and occupational safety.
Why AGC Pharma Chemicals’ Pharmaceutical Plant Stand Out?
- Over 40 years of CDMO experience in small molecule APIs
- Full regulatory compliance and global audit success
- Broad portfolio of technologies and reaction types
- Scalable infrastructure for clinical to commercial manufacturing
- Reliable supply chain, robust documentation, and tech transfer capabilities
We are more than a plant — we are your strategic pharmaceutical manufacturing partner.
Pharmaceutical Plant FAQ’s
1. What distinguishes AGC Pharma Chemicals’ pharmaceutical plant?
Our facilities are equipped for advanced and hazardous chemistry, HPAPI handling, and are certified under cGMP with consistent success in global audits.
2.Are your pharmaceutical plant suitable for high-potency compounds?
Yes. We have dedicated containment areas for the safe and compliant production of HPAPIs.
3. What scale of manufacturing can AGC Pharma Chemicals support?
We offer flexible scale, from small-scale clinical batches to multi-ton commercial production, all within our pharmaceutical plants.
Start Your Project with a World-Class Pharmaceutical Plant
Looking for a fully equipped and compliant pharmaceutical plant to develop and manufacture your API?
Contact AGC Pharma Chemicals today and learn how our facilities, technologies, and teams can support your molecule’s journey from lab to launch.
